These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

117 related articles for article (PubMed ID: 33520746)

  • 21. Neurocognitive performance and behavioral symptoms in patients with attention-deficit/hyperactivity disorder during twenty-four months of treatment with methylphenidate.
    Wang LJ; Chen CK; Huang YS
    J Child Adolesc Psychopharmacol; 2015 Apr; 25(3):246-53. PubMed ID: 25574708
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Randomised controlled trial of the short-term effects of osmotic-release oral system methylphenidate on symptoms and behavioural outcomes in young male prisoners with attention deficit hyperactivity disorder: CIAO-II study.
    Asherson PJ; Johansson L; Holland R; Bedding M; Forrester A; Giannulli L; Ginsberg Y; Howitt S; Kretzschmar I; Lawrie SM; Marsh C; Kelly C; Mansfield M; McCafferty C; Khan K; Müller-Sedgwick U; Strang J; Williamson G; Wilson L; Young S; Landau S; Thomson LDG
    Br J Psychiatry; 2023 Jan; 222(1):7-17. PubMed ID: 35657651
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Aripiprazole/Methylphenidate Combination in Children and Adolescents with Disruptive Mood Dysregulation Disorder and Attention-Deficit/Hyperactivity Disorder: An Open-Label Study.
    Pan PY; Fu AT; Yeh CB
    J Child Adolesc Psychopharmacol; 2018 Dec; 28(10):682-689. PubMed ID: 30148656
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Treatment effectiveness of combined medication/behavioural treatment with chinese ADHD children in routine practice.
    So CY; Leung PW; Hung SF
    Behav Res Ther; 2008 Sep; 46(9):983-92. PubMed ID: 18692170
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Lisdexamfetamine-Induced Psychosis in a Patient With a Neurodevelopmental Disorder.
    Gandhi R; Murray A
    Cureus; 2024 Jan; 16(1):e53349. PubMed ID: 38435908
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Effectiveness of methylphenidate and PUFA for the treatment of patients with ADHD: A double-blinded randomized clinical trial.
    Moghaddam MF; Shamekhi M; Rakhshani T
    Electron Physician; 2017 May; 9(5):4412-4418. PubMed ID: 28713515
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Clinical factors associated with decision to recommend methylphenidate treatment for children with ADHD in France.
    Courtabessis E; Pupier F; Surig L; Picot MC; Nogué E; Macioce V; Stein E; Purper-Ouakil D
    Eur Child Adolesc Psychiatry; 2018 Mar; 27(3):367-376. PubMed ID: 28983797
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Twenty-four-week treatment with extended release methylphenidate improves emotional symptoms in adult ADHD.
    Rösler M; Retz W; Fischer R; Ose C; Alm B; Deckert J; Philipsen A; Herpertz S; Ammer R
    World J Biol Psychiatry; 2010 Aug; 11(5):709-18. PubMed ID: 20353312
    [TBL] [Abstract][Full Text] [Related]  

  • 29. An Open-Label, Randomized Trial of Methylphenidate and Atomoxetine Treatment in Children with Attention-Deficit/Hyperactivity Disorder.
    Shang CY; Pan YL; Lin HY; Huang LW; Gau SS
    J Child Adolesc Psychopharmacol; 2015 Sep; 25(7):566-73. PubMed ID: 26222447
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Methylphenidate for children and adolescents with autism spectrum disorder.
    Sturman N; Deckx L; van Driel ML
    Cochrane Database Syst Rev; 2017 Nov; 11(11):CD011144. PubMed ID: 29159857
    [TBL] [Abstract][Full Text] [Related]  

  • 31. An exploration of site effects in a multisite trial of OROS-methylphenidate for smokers with attention deficit/hyperactivity disorder.
    Covey LS; Hu MC; Green CA; Brigham G; Hurt RD; Adler L; Winhusen T
    Am J Drug Alcohol Abuse; 2011 Sep; 37(5):392-9. PubMed ID: 21854282
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Treating nicotine dependence by targeting attention-deficit/ hyperactivity disorder (ADHD) with OROS methylphenidate: the role of baseline ADHD severity and treatment response.
    Nunes EV; Covey LS; Brigham G; Hu MC; Levin FR; Somoza EC; Winhusen TM
    J Clin Psychiatry; 2013 Oct; 74(10):983-90. PubMed ID: 24229749
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Differential responses of two related neurosteroids to methylphenidate based on ADHD subtype and the presence of depressive symptomatology.
    Molina-Carballo A; Justicia-Martínez F; Moreno-Madrid F; Cubero-Millán I; Machado-Casas I; Moreno-García L; León J; Luna-Del-Castillo JD; Uberos J; Muñoz-Hoyos A
    Psychopharmacology (Berl); 2014 Sep; 231(17):3635-45. PubMed ID: 24599397
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Effect of methylphenidate and folic Acid on ADHD symptoms and quality of life and aggression: a randomized double blind placebo controlled clinical trial.
    Ghanizadeh A; Sayyari Z; Mohammadi MR
    Iran J Psychiatry; 2013 Aug; 8(3):108-12. PubMed ID: 24454418
    [TBL] [Abstract][Full Text] [Related]  

  • 35. A double-blind, placebo-controlled, crossover study of osmotic release oral system methylphenidate in adults with ADHD with assessment of oppositional and emotional dimensions of the disorder.
    Reimherr FW; Williams ED; Strong RE; Mestas R; Soni P; Marchant BK
    J Clin Psychiatry; 2007 Jan; 68(1):93-101. PubMed ID: 17284136
    [TBL] [Abstract][Full Text] [Related]  

  • 36. A Counting Stroop Functional Magnetic Resonance Imaging Study on the Effects of ORADUR-Methylphenidate in Drug-Naive Children with Attention-Deficit/Hyperactivity Disorder.
    Shang CY; Chou TL; Hsieh CY; Gau SS
    J Child Adolesc Psychopharmacol; 2022 Nov; 32(9):467-475. PubMed ID: 36251766
    [No Abstract]   [Full Text] [Related]  

  • 37. Polyunsaturated fatty acids (PUFA) for attention deficit hyperactivity disorder (ADHD) in children and adolescents.
    Gillies D; Leach MJ; Perez Algorta G
    Cochrane Database Syst Rev; 2023 Apr; 4(4):CD007986. PubMed ID: 37058600
    [TBL] [Abstract][Full Text] [Related]  

  • 38. The adolescent outcome of children with attention deficit hyperactivity disorder treated with methylphenidate or methylphenidate combined with multimodal behaviour therapy: results of a naturalistic follow-up study.
    van der Oord S; Prins PJ; Oosterlaan J; Emmelkamp PM
    Clin Psychol Psychother; 2012; 19(3):270-8. PubMed ID: 21404369
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Sluggish Cognitive Tempo as a Possible Predictor of Methylphenidate Response in Children With ADHD: A Randomized Controlled Trial.
    Froehlich TE; Becker SP; Nick TG; Brinkman WB; Stein MA; Peugh J; Epstein JN
    J Clin Psychiatry; 2018; 79(2):. PubMed ID: 29489078
    [TBL] [Abstract][Full Text] [Related]  

  • 40. [Atomoxetine: a new treatment for Attention Deficit/Hyperactivity Disorder (ADHD) in children and adolescents].
    Purper-Ouakil D; Fourneret P; Wohl M; Rénéric JP
    Encephale; 2005; 31(3):337-48. PubMed ID: 16142049
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.